Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Alliacense Attorney to Manage European Licensing Activities

Instead of spending the license money on trying to buy back 100M shares, I hope RG uses the money to pursue more companies that have great potential for future growth, to further diversification beyond the MMP, perhaps a company that is listed on a better exchange and grow PTSC into it's 400M shares.

All the best,

Steve

Share
New Message
Please login to post a reply